Journal Mobile Options
Table of Contents
Vol. 5, No. 3, 2011
Issue release date: November 2011
Curr Urol 2011;5:137–144
(DOI:10.1159/000327467)

Interpreting the Clinical Significance of Quality of Life Score Changes after Radiotherapy for Localized Prostate Cancer

Pinkawa M. · Holy R. · Piroth M.D. · Klotz J. · Pfister D. · Heidenreich A. · Eble M.J.
a Department of Radiation Oncology; b Department of Urology, RWTH Aachen University, Aachen, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: The assessment of a clinical significance of certain quality of life score changes is often controversially discussed. Materials and Methods: The Expanded Prostate Cancer Index Composite questionnaire was completed before and 3 times after treatment for prostate cancer by 756 patients. Two criteria were considered as a clinically relevant change: score change corresponding to at least ‘very small problem’ from the patient’s point of view; score change with significantly increasing incidence of symptoms. These changes were compared to the 50% of standard deviation (SD) threshold. Results: Patients assess mean changes up to 4 points to be ‘no problem’, suggesting a mean change of 5 points to be the minimal important difference. With increasing score changes significant changes were noticed in an increasing number of items: up to 4 items if scores decreased 5–10 points. Additionally, an increasing percentage of patients were affected. These results correlated well with the 50% of SD threshold. Conclusions: The threshold of 5 points (or 5% of the instrument range) can be interpreted as the minimal important difference of clinical significance. The proposed criteria corresponded well to the distributionbased criterion based on the 50% of SD level.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50